Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice

Elisabeth R Barton1, Bing Jing Wang, Becky K Brisson

  • 1Department of Anatomy and Cell Biology, School of Dental Medicine, 441A Levy Building, 240 S. 40th Street, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. erbarton@biochem.dental.upenn.edu

Muscle & Nerve
|June 15, 2010
PubMed

Insights

Dysferlin-deficient mice show early diaphragm dysfunction, not limb muscle deficits. This finding aids in developing therapies for dysferlinopathies like limb girdle muscular dystrophy 2B.

Area of Science:

  • Biomedical research
  • Muscle physiology
  • Animal models of disease

Background:

  • Dysferlin deficiency causes limb girdle muscular dystrophy 2B and Miyoshi myopathy.
  • Current animal models exhibit slow pathology progression, hindering therapeutic screening.
  • A functional signature for dysferlin-lacking skeletal muscles is needed.

Purpose of the Study:

  • To identify a functional signature in skeletal muscles lacking dysferlin.
  • To assess the utility of the A/J mouse model for dysferlinopathy research.
  • To determine if diaphragm deficits can accelerate therapeutic evaluation.

Main Methods:

  • Isolated limb muscles and diaphragm from 10- and 36-week-old A/J and control mice were analyzed.
  • Measurements included force generation and susceptibility to eccentric contractile injury.
  • Fiber-specific analysis identified myosin heavy chain 2A-expressing fibers in the diaphragm.

Main Results:

  • Limb muscles maintained normal specific force at both ages.
  • The diaphragm exhibited significant deficits in specific force and eccentric injury susceptibility.
  • Diaphragm membrane ruptures during eccentric contractions occurred in myosin heavy chain 2A fibers.
  • Dysferlin content did not correlate with disease severity across wildtype muscles.

Conclusions:

  • The diaphragm, unlike limb muscles, shows early functional deficits in A/J mice.
  • These early diaphragm deficits may reduce the required age for therapy evaluation.
  • The A/J mouse diaphragm presents a promising model for accelerated dysferlinopathy research.

Related Concept Videos